Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs

por Tan, Enqing, Frew, Erica, Cooper, Jeff, Humphrey, John, Holden, Matthew, Mand, Amanda Restell, Li, Jun, Anderson, Shaya, Bi, Ming, Hatler, Julia, Person, Anthony, Mortari, Frank, Gould, Kevin, Barry, Shelly
Publicado 2021